Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions

Glioblastoma

Interventions

DEVICE

Standard Magnetic Resonance Imaging (MRI)

Standard MRI.

DEVICE

Advanced MRI.

Perfusion and diffusion MRI.

Trial Locations (1)

Froedtert Hospital & Medical College of Wisconsin, Milwaukee

All Listed Sponsors

lead

Medical College of Wisconsin

OTHER

NCT03297125 - Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI | Biotech Hunter | Biotech Hunter